AMN Healthcare Services (AMN) Earnings Analysis
AMN Healthcare Services (AMN) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS 2.1 USD vs 1.6 USD est (+31.3%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -39.76.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AMN next report earnings?
No confirmed upcoming earnings date is currently scheduled for AMN. This page updates as the calendar is published.
AMN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 2.1 USD | 1.6 USD | +31.3% | Beat |
| 2026-02-19 | 0.22 USD | 0.22 USD | 0% | Beat |
| 2025-05-08 | 0.45 USD | 0.19 USD | +136.8% | Beat |
| 2025-02-20 | 0.75 USD | 0.52 USD | +44.2% | Beat |
| 2024-11-07 | 0.61 USD | 0.58 USD | +5.2% | Beat |
| 2024-08-08 | 0.98 USD | 0.75 USD | +30.7% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
AMN valuation and analyst view
| Trailing P/E | -39.76 |
|---|---|
| Trailing EPS | -0.83399 USD |
| Price / book | 1.87 |
| Dividend yield | 0.00% |
| Market cap | 1.34B |
| Analyst consensus | Buy (10 buy / 6 hold / 1 sell) |
| Avg price target | 30 USD |
Related research pages
Frequently asked questions
When is AMN Healthcare Services (AMN)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AMN. This page updates as the calendar is published.
Did AMN beat earnings last quarter?
In its 2026-05-07 report, AMN posted EPS of 2.1 USD versus a 1.6 USD estimate — a beat of 31.3%.
What is AMN's earnings track record?
Over the last 6 reported quarters with consensus data, AMN beat estimates 6 times (100%).
What is AMN's current P/E ratio and EPS?
AMN trades at a trailing P/E of -39.76 on trailing EPS of -0.8339931108940415 USD.
What do analysts rate AMN?
Analyst consensus is "Buy" across 17 ratings (0 strong buy, 10 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 30 USD.